Akèy › Myelom Miltip › Kalifòni › Orange
Etid klinik pou Myelom Miltip nan Orange, CA
9 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote Orange (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 3
- University of California Irvine Medical Center, Orange
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Ap rekriteFaz 3
- UC Irvine, Orange
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Ap rekriteFaz 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Ap rekriteFaz 3
- Chao Family Comprehensive Cancer Center UCI, Orange
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Ap rekriteFaz 1
- UC Irvine Health, Orange
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Ap rekriteFaz 3
- Research Site, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Ap rekriteFaz 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Ap rekriteFaz 4
- UC Irvine Health, Orange
- UCI Health, Orange
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Ap rekriteFaz 1/2
- UC Irvine Health, Orange
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO27 etid
- Rochester, MN24 etid
- St. Louis, MO24 etid
- Columbus, OH24 etid
- Baldwin Park, CA23 etid
- Chicago, IL22 etid
Lòt etid nan Orange
- Kansè Poumon ki pa ti selil25 etid
- Kansè Metastatik20 etid
- Kansè kolorektal16 etid
- Kansè ovè16 etid
- Kansè pankreyas15 etid
- Kansè nan tete14 etid
- Kansè poumon14 etid
- Kansè pwostat14 etid
- Kansè fwa (Kasinòm epatoselilè)14 etid
- Melanom14 etid
- Leksemi mieloïd egi13 etid
- Kansè (tout kalite)13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.